Phenol-derived CVFM analog inhibitors of Ras Farnesyltransferase possessing cellular in vitro activity

Author： Caliendo G.   Fiorino F.   Grieco P.   Perissutti E.   Ramunno A.   Santagada V.   Albrizio S.   Califano D.   Giuliano A.   Santelli G.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.33, Iss.9, 1998-09, pp. : 725-732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Non-peptidic Inhibitors of Ras Farnesyltransferase

By Salaun M.C.   Deweer S.   Goossens J.F.   Houssin R.   Pommery J.   Hénichart J.P.  

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 3, 1999-03 ,pp. : 173-176

Pharmaceutical Press

Access to resources Recommend Favorite

Non-peptidic, Non-prenylic Bisubstrate Farnesyltransferase Inhibitors, 4. Effect on Farnesyltransferase Inhibitory Activity of Conformational Restrictions in the Central Group

By Schlitzer M.   Sattler I.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 3, 2000-03 ,pp. : 117-124

Pharmaceutical Press

Access to resources Recommend Favorite

Non-Peptidic, Non-Prenylic Bisubstrate Farnesyltransferase Inhibitors. Effect of a Carboxyl Group at the Central Group on Farnesyltransferase Inhibitory Activity

By Schlitzer M.   Sattler I.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 11, 2000-11 ,pp. : 507-512

Pharmaceutical Press

Access to resources Recommend Favorite

Increasing Complexity of Farnesyltransferase Inhibitors Activity: Role in Chromosome Instability

By  

Current Cancer Drug Targets, Vol. 3, Iss. 2, 2003-04 ,pp. : 109-118

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors

By  

Current Cancer Drug Targets, Vol. 10, Iss. 2, 2010-03 ,pp. : 192-199

Bentham Science Publishers

Access to resources Recommend Favorite